October 10, 2025

RM completes £13.5m oversubscribed placing

RM plc has confirmed the successful completion of its placing, raising gross proceeds of approximately £13.5 million through the issue of 14.2 million new shares at..

Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC)

Victorian Plumbing Group plc (LON:VIC)was the topic of conversation when DirectorsTalk interviewed Gervais Williams, Co-Fund Manager of The Diverse Income Trust plc (LON:DIVI) on what’s driven..

RM launches £13.5m placing to fund assessment growth strategy

RM plc has announced a proposed placing to raise approximately £13.5 million through the issue of new shares at 95 pence per share...

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Exploring a Promising 66.83% Potential Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is catching the eye of many investors in the biotechnology sector, boasting an impressive potential upside of 66.83%. Headquartered in Menlo..

AngioDynamics, Inc. (ANGO) Stock Analysis: A Promising 66% Upside for Investors in the Medical Tech Sphere

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the medical technology field, offers a tantalizing prospect for investors seeking exposure to the healthcare sector. With a..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 366.92% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is making waves in the biotech sector with its innovative approach to targeting G protein-coupled receptors (GPCRs) through its proprietary GEODe..

Cel-Sci Corporation (CVM): A Biotech Stock with a Staggering 1,712% Upside Potential

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, is drawing considerable attention from investors, thanks to its promising pipeline and the staggering potential upside of over..

Inventiva S.A. (IVA): Investor Outlook on the Biotech Stock with a 187% Upside Potential

Inventiva S.A. (IVA), a clinical-stage biopharmaceutical company headquartered in Daix, France, is making waves in the biotechnology sector with its promising pipeline of oral small molecule..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a Challenging Market with a Diverse Product Portfolio

For investors looking at the healthcare sector, Tilray Brands, Inc. (NASDAQ: TLRY) presents an intriguing case, especially within the niche of specialty drug manufacturing. Headquartered in..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling Its 93.40% Potential Upside in the Booming Biotech Sector

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company, is capturing attention in the biotechnology sector with its promising pipeline of treatments targeting central nervous system (CNS)..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem with 158% Upside Potential

Precigen, Inc. (NASDAQ: PGEN), a forward-thinking player in the biotechnology sector, is making waves with its innovative gene and cell therapy solutions. With a market capitalization..

PureTech Health (PRTC) Stock Analysis: A Biotech Pioneer with 155% Upside Potential

For investors with an appetite for high-growth opportunities in the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case. Based in Boston, Massachusetts, and..

Arvinas, Inc. (ARVN) Stock Analysis: Potential 89% Upside with Promising Biotech Innovations

Arvinas, Inc. (NASDAQ: ARVN) has captured the attention of investors with its innovative approach to biotechnology, focusing on developing therapies to degrade disease-causing proteins. As a..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 170% Upside Potential in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm, is currently attracting significant investor attention with its robust pipeline aimed at addressing unmet medical needs, particularly..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 62.15% Potential Upside Awaits Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a significant player in the medical devices sector, is attracting attention with its promising upside potential, despite recent financial challenges. The..

Humacyte, Inc. (HUMA) Stock Analysis: Significant 413.94% Potential Upside Ignites Investor Interest

Humacyte, Inc. (NASDAQ: HUMA), a pioneering company in the healthcare sector, stands out in the biotechnology industry with its innovative approach to developing implantable bioengineered human..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with a Focus on Innovation

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, operates within the specialized medical devices industry. With a current market capitalization of $411.91 million,..

Abivax SA (ABVX) Investor Outlook: A Biotech with a 22.64% Potential Upside

Abivax SA (ABVX), a prominent player in the biotechnology sector, is capturing investor interest with a compelling growth narrative and substantial upside potential. With its headquarters..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a Challenging Landscape with Strategic Collaborations

Investors eyeing Fortrea Holdings Inc. (NASDAQ: FTRE) are met with a complex picture defined by an evolving market position and strategic initiatives within the healthcare sector...

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a 280% Potential Upside in the Biotechnology Sector

Investors keen on the biotechnology sector should keep a close watch on MBX Biosciences, Inc. (MBX), a promising player with a focus on precision peptide therapies..

Search

Funds

October 10, 2025

RM completes £13.5m oversubscribed placing

RM plc has confirmed the successful completion of its placing, raising gross proceeds of approximately £13.5 million through the issue of 14.2 million new shares at 95 pence each...

RM launches £13.5m placing to fund assessment growth strategy

RM plc has announced a proposed placing to raise approximately £13.5 million through the issue of new shares at 95 pence per share...
Search

Funds

October 10, 2025

FTSE 100

Funds